Articles tagged with: Alvocidib
News»

Yesterday was the second day of the 2012 American Society of Hematology (ASH) annual meeting. Although the myeloma-related sessions got a bit of a late start, the day featured a wide range of interesting presentations about multiple myeloma.
Many myeloma-related oral presentations were given in the afternoon and were summarized in updates published yesterday and earlier today.
During the evening yesterday, a poster session took place where important new research findings were summarized in posters displayed throughout a large conference hall. The studies covered a variety of myeloma-related topics, ranging …